Germany vs New Zealand: Proportion of isolates with decreased susceptibility or resistance
Germany
0
in 2020
New Zealand
0.1
in 2020
Germany rank
13th
New Zealand rank
11th
Proportion of isolates with decreased susceptibility or resistance over time
- Germany
- New Zealand
How they compare
New Zealand currently reports 0.1 against 0 in Germany, a difference of 0.1.
The two have swapped places 2 times across 9 shared years of data; in 2009 it was New Zealand ahead.
Germany ranks 13th and New Zealand ranks 11th of 52 countries.
Across the 3 decades both report, Germany averaged higher in 1 and New Zealand in 1.
Head to head by decade
| Decade | Germany | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0 | 0 | 0 | — |
| 2010s | 1.2 | 0.3779 | 0.8242 | Germany |
| 2020s | 0 | 0.1 | 0.1 | New Zealand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Germany or New Zealand?
- New Zealand, at 0.1 against 0 in Germany as of 2020.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Germany and New Zealand?
- 0.1, with New Zealand ahead.
- How many years of comparable data are there for Germany and New Zealand?
- 9 years are reported by both, from 2009 to 2020.
- How do Germany and New Zealand rank globally for proportion of isolates with decreased susceptibility or resistance?
- Germany ranks 13th and New Zealand ranks 11th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.